Perioperative epidural anaesthesia and analgesia (PEA) has become controversial because of its doubtful effect on patient outcome and its serious complications. These scientific considerations have been affected by the changing medicolegal climate in Australia and has led to a reappraisal of this technique in our practice of anaesthesia. Many anaesthetists are now uncertain about indications, consent requirements, optimal management and the prevention and early detection of complications of PEA. The aim of this paper is to present a personal perspective of the place and use of PEA in current anaesthetic practise. The primary indication for PEA should be pain relief for open abdominal or thoracic surgery because there is level 1 evidence that it provides better analgesia than parenteral opioids. There is reasonable evidence that outcome is improved but the studies are conflicting. Coagulation status needs to be assessed carefully before the insertion and removal of epidural catheters. Consent issues are difficult in practice, both from the timing and the content of the information. The decrease in the use of PEA may paradoxically result in more complications as loss of expertise becomes an issue. PEA is labour intensive and therefore needs the support of an Acute Pain Service in order to use this technique safely and recognise problems early. Permanent neurological complications are the most feared complication of this technique but early recognition of these problems can improve outcome. These complications need to be balanced against the potentially serious hypoxaemia associated with parenteral opioids used for postoperative pain relief.
Perioperative epidural anaesthesia and analgesia (PEA) has been the subject of many papers over the past 10 years focusing on two main aspects, its effect on patient outcome and its serious complications.
by the changing medicolegal climate in Australia and this has led to a reappraisal of this technique in our practice of anaesthesia [1] [2] [3] . Many anaesthetists are now uncertain about indications, consent requirements, optimal management and the prevention and early detection of complications of PEA. The aim of this paper is to present a personal perspective of the place and use of PEA in current anaesthetic practice.
INDICATIONS
The indications for epidural anaesthesia and analgesia need to be carefully assessed in the careful assessment of expertise in PEA and the practice setting ( Figure 1 ). Indications will not be considered for epidural anaesthesia alone, or for obstetrics or paediatrics, all of which require special consideration.
Primary indication: postoperative pain relief
Epidural analgesia has been shown to provide superior postoperative analgesia compared with parenteral opioids. Two meta-analyses of the literature support this statement. Block et al 4 found 100 articles to meet their inclusion criteria to answer the question of whether epidural analgesia provides better pain control than parenteral opioid analgesia. Thirty-six percent of patients were having abdominal surgery, 24% thoracic surgery and 12% lower limb surgery. The epidural analgesia consisted of local anaesthetic and opioid in 32% of patients and opioid alone in 53% of patients. The parenteral opioids were morphine (40%), fentanyl (21%) and sufentanil (11%). They concluded that epidural analgesia, regardless of analgesic agent, location of catheter and type and time of pain assessment, provided better postoperative analgesia compared with parenteral opioids.
Wu et al 5 meta-analysis published two years later. They restricted their study to a comparison of patient controlled and continuous infusion epidural analgesia versus intravenous patient controlled analgesia (PCA) with opioids. They found 50 articles suitable, which included 1625 patients randomised to epidural analgesia and 1583 to intravenous PCA. Again, abdominal surgery and thoracic surgery was performed in 58% of patients and lower limb surgery in 14% of patients. The epidural analgesia consisted of local anaesthetic alone in 4%, opioids alone in 28% and combined local anaesthetic and opioids in 68%. Intravenous PCA morphine was used in 76% of patients and fentanyl in 6%. Their conclusion was that "epidural analgesia, almost without exception, regardless of analgesic agent, epidural regimen and type and time of pain assessment, provided superior postoperative analgesia compared to intravenous patient controlled analgesia". management 6 published by the Australian and New Zealand College of Anaesthetists (ANZCA) and approved by the National Health and Medical Research Council supported PEA as providing better postoperative pain relief compared with parenteral opioid administration and supported this statement with Level 1 evidence.
Secondary indication: improving outcome
The controversy of the role of epidural anaesthesia and analgesia on improving outcome has now raged for nearly 20 years. Yeager et al 7 There are many methodological problems with many of the studies of outcome. Most importantly, they have been underpowered. However, when subjected to meta-analysis, Rogers et al 9 in 1997 concluded that "neuraxial blockade reduces postoperative mortality and other serious complications". Two more recent meta-analyses of the literature are less supportive of an improvement in outcome 10, 11 . An analysis of the literature by Ballantyne et al 10 strongly suggests that there is no reduction in major morbidity or mortality. Nishimori et al 11 were more supportive of PEA for abdominal aortic surgery; they concluded that it provided better pain relief and reduced prolonged postoperative ventilation, overall cardiac complications, myocardial infarction, gastric complications and renal complications.
The primary mechanism for improving outcome is to surgery allowing for more rapid postoperative recovery 12 . Extensive epidural analgesia with local anaesthetic agent will reduce the stress response to lower abdominal and lower limb surgery 13 . The stress response to upper abdominal or thoracic surgery by extensive epidural local anaesthetic blockade from T4 to S5 14 . The stress response is complex and extensive sympathetic block will not block the response to agents released into the blood stream by local trauma 14 .
blockade should be established prior to the surgical incision that triggers the response; post incisional epidural anaesthesia can only attenuate the response 14 .
The two most recent multicentre trials may not have achieved this requirement. Park et al 15 established epidural anaesthesia to T6 or higher before induction of general anaesthesia using 0.5% bupivacaine with adrenaline (1:200,000) and maintained adequate epidural anaesthesia with an additional 5 to 10 ml FIGURE 1: Factors affecting risk/benefit for PEA stress response to surgery, because of the requirement to provide an extensive sympathetic block from T4 to S5. They would, however, be adequate for postoperative pain relief. The MASTER trial 8 to allow participating centres to achieve optimal clinical management" but it did not indicate whether epidural anaesthesia was clearly established before induction of general anaesthesia and hence before the surgical incision. Nevertheless they did conclude: "However, the improvement in analgesia, reduction in respiratory failure and the low risk of serious adverse consequences suggest that many high risk patients undergoing major intra-abdominal surgery will receive substantial thesia intraoperatively with continuing postoperative epidural analgesia".
Beattie et al 16 performed a meta-analysis to determine whether postoperative epidural analgesia decreased postoperative myocardial infarction (PMI). Their search identified 11 suitable randomised controlled trials that studied 1173 patients. Subgroup analysis of patients receiving postoperative thoracic epidural anaesthesia showed a statistically significant reduction in PMI compared with systemic analgesia. The PMI rate was 3.6% with postoperative epidural analgesia compared to 8.5% with systemic analgesia (P=0.04).
The assessment of scientific evidence by ANZCA 6 considers that there is Level 1 evidence for thoracic epidural local anaesthetics reducing pulmonary infections, improving bowel recovery after abdominal surgery and for reducing the incidence of postoperative myocardial infarction.
In summary, epidural anaesthesia with postoperative epidural analgesia is associated with superior analgesia for open thoracic and abdominal surgery and outcome might be improved in these patients. The magnitude of the improved outcome may not be great and is still controversial. There is less evidence for improved outcome with lower limb surgery, which is associated with less pain. Moreover, peripheral nerve blocks are an option if regional analgesia is to be used.
CONTRAINDICATIONS
Patient refusal, local and systemic infection and impaired coagulation (Table 1) are the major contraindications to perioperative epidural anaesthesia and analgesia. Infection and coagulopathy however deserve special consideration.
Infection
Clearly infection at or near the site of insertion of an epidural is a contraindication. Patients with systemic infection need to be assessed more carefully, a contraindication, but infections such as respiratory infection may not represent contraindications PEA, particularly if the patient is receiving appropriate antibiotics.
Patients with compromised immunity may also be at greater risk of epidural abscess 17 . These include patients with diabetes mellitus, steroid or other immunosuppressive therapy, malignancy, pregnancy, HIV infection, alcoholism and cirrhosis. These 
Impaired coagulation
The patient's coagulation needs to be assessed very carefully before inserting an epidural needle or catheter because epidural haematoma can be a devastating complication. Detailed consideration and recommendations are outlined in the second American Society of Regional Anesthesia consensus conference on neuraxial anaesthesia and anticoagulation 18 . Full anticoagulation (with heparin or warfarin) or thrombolytics is an absolute contraindication. The main problem arises when patients are receiving a combination of antiplatelet and other drugs, which may result in bleeding problems. The two most important drugs to consider are low molecular weight heparin (LMWH) and the antiplatelet drug clopidogrel. LMWH has now become the most frequently used drug for the prevention of postoperative deep venous thrombosis. If the patient is receiving a single daily prophylactic dose of enoxaparin (Clexane ® ), insertion of the epidural should occur at least 10 to 12 hours after the last dose of LMWH and the catheter should not be removed until at least 10 to 12 hours after the last dose, with recommencement of LMWH at least two hours after removal.
Clopidogrel (Plavix ® Iscover ® ) is being increasingly used for a variety of indications, especially for vascular stent and coronary stent patients. This is a potent antiplatelet drug and bleeding times are of 375 mg. Platelet inhibition persists for the life of the platelet and only diminishes in proportion to platelet renewal. Only one case of subararchnoid haemorrhage after lumbar puncture in a patient receiving aspirin and clopidrogrel has been reported 19 , but the potent antiplatelet action of this drug is neuraxial block. It is recommended that clopidogrel be stopped seven days prior to epidural insertion. Clopidogrel has a half-life of approximately 12 hours and platelet replenishment occurs at a rate of about 10% of platelet mass per day so the sevennew platelet count to be over 100,000 × 10 9 /l. Finally, patients who are receiving a combination of these drugs that may increase the risk of bleeding into the epidural space should be assessed very carefully and alternate methods of pain relief to PEA considered.
CONSENT FOR PEA
Consent for PEA is no different from the consent for any medical procedure, including the alternative, PCA opioids. Providing the patient with adequate information before surgery and anaesthesia is now fully supported and recommended by our professional bodies 20 . The problem for anaesthesia is the complexity of the information and the inability to provide this information well before the day of surgery. These problems are exacerbated when many patients are admitted on the day of surgery.
Information
The real issue with PEA consent is that we have clear evidence that it can provide the best pain relief for open abdominal, open thoracic surgery and possibly lower limb surgery, with good evidence that some outcomes are improved. However, PEA is associated with some rare but serious risks. The most serious risk of PEA is permanent neurological damage, which includes both nerve damage and spinal cord damage. When discussing these risks with patients, I prefer the term 'spinal cord damage', rather than 'paraplegia', which is a very emotive term and risks of PEA. If the patient requests more information about permanent neurological damage then the whole spectrum of disabilities can be discussed. However, others feel that it is important to mention the risk of paraplegia, albeit extremely Evidence 6 includes a guide to patients 21 , which among other information states that "if the abscess or blood clot was big enough to press on the spinal cord, then permanent nerve damage or paraplegia could occur". Patients should be informed that PCA opioids often provide less complete pain relief for open thoracic and open abdominal surgery, may be less protective than PEA and can be associated with serious side-effects of their own. Often there is a focus on the complications of PEA with little consideration of those associated with PCA opioids. For example, the rare serious side-effects of opioids are not mentioned in the ANZCA's guide for patients 21 .
It may be unrealistic to expect patients to make a fully informed decision in this area, where many anaesthetists cannot agree. Therefore, recommendations should be made on a patientby-patient basis, based on our knowledge of the best available evidence for PEA or PCA opioids and consideration of available skills and support services.
Timing anaesthetic procedures should be provided a reasonable time before anaesthesia to patients so that they can give truly informed consent. Information provided on the day of surgery, for surgery and presumably anaesthesia is considered not to be adequate by the Medical Board of Victoria 22 . A mechanism needs to be developed to inform the patients well before anaesthesia so that they can discuss some aspects including the role of PEA or PCA opioids with the anaesthetist carrying out the procedure.
MAINTENANCE OF EXPERTISE
The strong reluctance to perform neuraxial blocks 1 could paradoxically increase the incidence of serious complications of PEA. Quality assurance data in our Department (St Vincent's Hospital, Melbourne) indicates a 39% reduction of PEA use over the past 10 years. This has occurred in a Department of Anaesthesia that has had a strong commitment to regional anaesthesia and where 35±4% (mean±SD) of the anaesthesia in the past 10 years has been regional anaesthesia or combined general with regional anaesthesia. The utilisation of PEA in hospitals less committed to regional anaesthesia could be even lower.
Numbers of PEA performed
The insertion of epidurals requires the maintenance of a skill that requires continual practice to ensure that the technique is carried out safely and effectively. Performing the technique a certain number of times per year could ensure the maintenance of this skill. The real question is: what is this number? It has been suggested that anaesthetic trainees reach a success rate of 60% with 20 epidural anaesthetic procedures and 80% with 90 procedures 23 . American anaesthesiology residents are expected to perform a minimum of 50 epidurals during their training 24 . ANZCA has should perform. These numbers may seem low for trainees, but the question of numbers for consultant anaesthetists academic medical centres in the U.S.A. 25 revealed that these departments performed an average of 16 (range 1 to 90) thoracic epidural placements each month per centre. It was not clear whether those procedures were actually performed by the consultant anaesthesiologist or that they supervised those procedures. In a training institution in Australia a consultant anaesthetist would probably be expected to supervise many epidural procedures, but perhaps not perform many personally.
If an anaesthetist considers that PEA is indicated but has not been able to maintain expertise in this technique, the procedure could be performed by a colleague with appropriate expertise, who would then continue the management of the PEA postoperatively.
Competition from spinal anaesthesia
Spinal anaesthesia has increased in popularity needles. These needles have reduced the incidence of post lumbar puncture headache to levels where this problem is no longer a disincentive to the performance of spinal anaesthesia in the younger age groups.
Spinal anaesthesia also has the added advantage of rapid onset and a higher success rate than single shot epidurals. Quality assurance records in our department indicate a growth of spinal anaesthesia from 946 per year to 1302 per year over a 10-year period (1996 to 2005) . This has led to a corresponding reduction in the use of epidural anaesthesia (774 per year to 468 per year), thus reducing the opportunities for anaesthetic trainees to gain epidural expertise. The problem of obtaining and maintaining epidural skills now requires further attention.
MANAGEMENT OF PEA
Postoperative epidural analgesia requires ongoing management by anaesthetists from the time of insertion until a few days after withdrawal of the epidural catheter. This is essential to ensure the quality of pain relief and to identify and minimise complications. Some aspects of management will be considered.
Acute Pain Service
PEA is labour intensive and requires regular review by experts in the management of acute postoperative pain. Our pain service reviews patients at least twice daily and more frequently if indicated 26 . The anaesthetist inserting the epidural catheter should retain overall responsibility, but must usually delegate ongoing management of patients with PEA to the acute pain management team. A single anaesthetist frequent patient review that is provided by an acute pain service.
Duration of PEA
If outcome improvement is the aim, then the duration of PEA should be about 72 hours because the cardiovascular stress response lasts at least this time. There should be a good plan for the transition from PEA to other forms of postoperative pain relief after this time. There is evidence that PEA duration of less than 24 hours is unlikely to improve outcome and yet continuing PEA beyond 72 hours may increase the possibility of epidural abscess 17 . The evidence for optimal duration of PEA to improve outcome is not well studied.
Accidental dislodgement
The frequency of accidental dislodgement of epidural catheters is reported to be 6 to 13% 8, 26 . This remains high for a technique with the potential for rare but serious complications. Techniques need to be used to reduce this accidental dislodgement rate, particularly in patients on LMWH where the random dislodgement of epidural catheters may predispose to epidural haematoma.
COMPLICATIONS
The real question related to the use of PEA outcome justify exposure to the rare but devastating complication of permanent neurological damage. However, PCA opioids have complications which are less well reported, but nevertheless serious, as they may also lead to patient morbidity and mortality.
PEA-permanent neurological damage
Permanent neurological damage after PEA can occur as a result of compression of the spinal cord by epidural haematoma or abscess, spinal cord damage from local anaesthetic toxicity, or by direct needle establish, but ranges from 0.005 to 0.05% 9 (1:20,000 to 1:2000) have been reported. The study by Moen et al 27 is probably the most comprehensive retrospective study performed to detect serious neurological complications after central neuraxial block. Their comprehensive survey in Sweden covered the decade practice. A total of 127 complications were reported of which 85 patients developed permanent neurological damage. All serious complications were more frequent with the epidural blocks (71 in 450,000 or 0.016%) compared to the spinal blocks (56 in 1,260,000 or 0.004%). Female patients having knee arthroplasty had the highest incidence of epidural haematoma (1:3600). The authors postulate that this problem occurs because Scandinavian postmenopausal women have the world's highest incidence of osteoporosis with increased spinal pathology. This concern prompted the authors to conclude that peripheral nerve blocks or intrathecal opioids could be a prudent alternative to PEA for postoperative analgesia in these patients.
Auroy et al 28, 29 reported two prospective surveys of serious complications related to regional anaesthesia in France. Neurological injury 28 was reported in 12 of 30,413 patients who had epidurals (0.039%) or 1 in 2500 patients. Unfortunately, they do not neurological damage. Thirty-four neurological complications were reported from 103,730 regional case of paraplegia occurred following a combined epidural block with general anaesthesia, an incidence of 1:30,000.
The second prospective survey occurred in a 10-month period in 1998 and 1999 29 . There was one case of meningitis reported in the 5561 nonobstetrical epidural blocks and no other neurological complication. There was no statement about the outcome from the case of meningitis.
A recent review article about epidural abscesses estimated the true incidence of this problem might be in the order of one in 1000 in surgical patients 17 . Again the incidence of severe permanent is unclear but is suggested to be about 27% of patients who develop this rare problem. A prospective audit of our acute pain service over 16 years showed that there were six abscesses in 8210 patients having PEA. Fortunately, none of the patients had permanent neurological damage.
Permanent neurological complications are devastating and their consequences are minimised only by early diagnosis and early treatment. Early diagnosis can occur only if patients are assessed for excessive motor block while the PEA is working and checked for back pain and fever regularly. This surveillance should occur for several days after the PEA is discontinued. Patients should be given an information sheet noting the symptoms and signs of neurological complications so that they seek early medical help if these persist or progress 17 . Any suggestion of this complication should immediately trigger an early MRI and neurosurgical consultation.
Opioids-hypoxia
PCA opioids are usually considered to be free from serious complications and therefore safer than PEA. However, episodic hypoxaemia occurring with opioids is well recognised 30 . These episodes could result in the serious complications of cerebral damage or myocardial ischaemia but the incidence has not been established. The relationship between opioids and serious morbidity is less direct than with epidurals and neurological damage, so it is often ignored.
usually report a much smaller number of patients than those detailing the complications of PEA.
Walder et al 31 performed a systematic review of of PCA for acute postoperative pain. They analysed data from 32 randomised controlled trials published between 1982 and 1999. These trials allowed a comparison of 1029 patients having PCA opioid and 1082 controls receiving the same opioid intravenously, intramuscularly or subcutaneously. Only four of of oxygen saturation of less than 90%, totalling 180 patients. Hypoxia occurred in 15% of PCA patients and 18% of controls. Cashman and Dolin 32 carried out a systematic review of the literature to establish the respiratory and haemodynamic effects of acute postoperative pain management. They found 24 studies where an oxygen saturation of less than 90% was reported. The incidence of S a O 2 <90% was 17% in patients receiving intramuscular opioids (246 patients), 11.5% in patients receiving PCA opioids (707 patients) and 15% in patients receiving epidurals (563 patients). Thus it may well be argued that PEA and PCA opioids result in a similar frequency of postoperative hypoxia and that this complication does not separate the two techniques from a safety point of view.
CONCLUSIONS
The medicolegal concerns about PEA should not dominate the practice of this important technique. The superior quality of pain relief for open thoracic, open abdominal and lower limb surgery is well established. There is good evidence for some improved outcomes. Anaesthetists need to ensure that PEA is as safe as possible by performing the technique only if they have maintained their expertise and are able to be supported by an acute pain service. The patient's coagulation status should be carefully considered before insertion of an epidural catheter and before its removal. It should be recognised that parenteral opioids may also rarely have serious complications. The serious neurological complications of PEA must be diagnosed early to limit their degree or open thoracic and abdominal surgery, particularly if the patient has preoperative respiratory disease. Lower limb orthopaedic surgery may have greater risks of neurologic damage with PEA, so that other postoperative analgesic regimens should be considered. The use of PEA in a particular patient should be made with careful consideration of all the aspects of management.
